This enzyme promotes transforming growth factor-beta (TGF-beta)-activated kinase 1 deubiquitination and inhibits TAK1 phosphorylation, and subsequent activation of the NF-κB signaling pathway, which ultimately induces the inhibition of the anti-tumor effect of T cells.88 Here, MAP3K7 is linked to neoplasm.